The National Agency for Food and Drug Administration and Control (NAFDAC) has warned about falsified Oxycontin 80mg detected in Switzerland’s unregulated market, posing serious health risks.
NAFDAC, in Public Alert No. 07/2025, said the counterfeit drug—reported to the World Health Organization (WHO) by manufacturer MUNDIPHARMA—contains potent synthetic opioids instead of oxycodone.
Fake Oxycontin Poses High Overdose Risk
Lab tests in Zurich, Switzerland, revealed the fake tablets likely contain nitazene compounds, synthetic opioids far stronger than oxycodone, increasing overdose risks.
Potential dangers include:
⚠️ Severe respiratory depression
⚠️ Low blood pressure
⚠️ Coma or fatal overdose, especially when mixed with alcohol or benzodiazepines
How to Spot the Fake Oxycontin
🔹 Incorrect batch/expiry date placement: Appears on the front of the blister strip instead of the back.
🔹 Misaligned details: Expiry date is on the left and batch number on the right, opposite of the genuine version.
NAFDAC Intensifies Surveillance
The agency has ordered nationwide checks to remove counterfeit Oxycontin from circulation and urged importers, distributors, and retailers to source medicines only from licensed suppliers.
Report Suspicious Drugs
📞 Call NAFDAC: 0800-162-3322
📧 Email: sf.alert@nafdac.gov.ng
🌐 Visit: www.nafdac.gov.ng
Consumers and healthcare professionals can also report adverse effects via the Med-Safety app (Android/iOS).
Post a Comment